Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

NCT00376012 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Tuberculosis
Human Immunodeficiency Virus Infections

Interventions

DRUG: Anti-TB drugs (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide)
DRUG: Anti-TB drugs (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide)

Sponsor

Tuberculosis Research Centre, India